Trexquant Investment’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-37,830
| Closed | -$596K | – | 1908 |
|
2024
Q1 | $596K | Buy |
+37,830
| New | +$596K | 0.01% | 1097 |
|
2023
Q4 | – | Sell |
-24,516
| Closed | -$492K | – | 1864 |
|
2023
Q3 | $492K | Sell |
24,516
-15,942
| -39% | -$320K | 0.01% | 1028 |
|
2023
Q2 | $1.14M | Buy |
40,458
+17,371
| +75% | +$490K | 0.03% | 714 |
|
2023
Q1 | $397K | Buy |
+23,087
| New | +$397K | 0.01% | 1088 |
|
2022
Q3 | – | Sell |
-7,298
| Closed | -$205K | – | 1901 |
|
2022
Q2 | $205K | Buy |
7,298
+1,323
| +22% | +$37.2K | 0.01% | 1345 |
|
2022
Q1 | $276K | Sell |
5,975
-9,086
| -60% | -$420K | 0.01% | 1050 |
|
2021
Q4 | $1.27M | Buy |
+15,061
| New | +$1.27M | 0.08% | 328 |
|
2021
Q3 | – | Sell |
-5,969
| Closed | -$318K | – | 1546 |
|
2021
Q2 | $318K | Buy |
+5,969
| New | +$318K | 0.03% | 685 |
|
2021
Q1 | – | Sell |
-6,798
| Closed | -$353K | – | 1528 |
|
2020
Q4 | $353K | Buy |
+6,798
| New | +$353K | 0.04% | 603 |
|